Karo Pharma AB buy Raymond James
Start price
16.01.25
/
50%
€5.44
Target price
16.01.26
€49.43
Performance (%)
-
End price
17.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Raymond_James for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock, up previously from $46.00.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten